Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - ephedrine hydrochloride, quantity: 30 mg - injection, solution - excipient ingredients: water for injections - ephedrine hydrochloride injection is indicated in the treatment of hypotension secondary to spinal anaesthesia.

Malta - English - Medicines Authority

neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - cetirizine dihydrochloride, pseudoephedrine hydrochloride - prolonged-release tablet - cetirizine dihydrochloride 5 mg pseudoephedrine hydrochloride 120 mg - nasal preparations

Kenya - English - Pharmacy and Poisons Board

bayer consumer care ag peter merian strasse 84,4052 p.o. box 4002 - loratidine & pseudoephedrine sulphate - prolonged-release tablet - 5 mg & 120 mg - nasal decongestants for systemic use:

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - pseudoephedrine hcl 120 mg, cetirizine dihydrochloride 5 mg - 120 mg, 5 mg

Singapore - English - HSA (Health Sciences Authority)

organon singapore pte. ltd. - (ir layer) desloratadine, micronized; (sr layer) pseudoephedrine sulfate - tablet, delayed release - 2.5mg - (ir layer) desloratadine, micronized 2.5mg; (sr layer) pseudoephedrine sulfate 120.0mg

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - doxazosin mesilate - tablet prolonged release - 4 milligram - alpha-adrenoreceptor antagonists

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis ireland limited - clomipramine hydrochloride - tablet - 75 milligram(s) - non-selective monoamine reuptake inhibitors; clomipramine

Israel - English - Ministry of Health

bayer israel ltd - loratadine; pseudoephedrine sulfate - tablets prolonged release - loratadine 5 mg; pseudoephedrine sulfate 120 mg - loratadine - loratadine - relief of symptoms of seasonal allergic rhinitis when both the antihistaminic properties and the nasal decongestant activity are desired.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - pseudoephedrine hydrochloride, quantity: 120 mg; fexofenadine hydrochloride, quantity: 60 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; pregelatinised maize starch; carnauba wax; colloidal anhydrous silica; stearic acid; macrogol 8000; hypromellose; macrogol 400 - for the relief of the symptoms of seasonal allergic rhinitis with nasal congestion when both the antiallergic properties of fexofenadine hydrochloride and the decongestant activity of pseudoephedrine hydrochloride are required.

Ireland - English - HPRA (Health Products Regulatory Authority)

b & s healthcare - aminophylline hydrate - tablet prolonged release - 225 milligram